4basebio PLC (id:3942 4BB)
1.18K GBP
Opening hours: 08:00 - 16:30 (GMT Standard Time: 12/24/2024 4:18:01 PM)
Exchange open, closes in 11 minutes
3.00 GBP (3.00%)
3.00 GBP (3.00%)
-10.57 GBP (-10.57%)
-23.05 GBP (-23.05%)
74.26 GBP (74.26%)
703.39 GBP (703.39%)
About 4basebio PLC
Market Capitalization 185.38M
4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. The company offers AVV and Lentivirus manufacturing services for use in gene therapies and vaccines. It also offers access to its targeted non-viral delivery platform, Hermes. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.
| Headquarters (address) |
25 Norman Way Cambridge CB24 5QE United Kingdom |
| Phone | 44 1223 967 943 |
| Website | https://www.4basebio.com |
| Employees | 101 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | 4BB |
| Exchange | London Stock Exchange |
| Currency | GBP |
| 52 week range | 640.00 - 1.82K |
| Market Capitalization | 185.38M |
| P/E trailing | -1,911.29 |
| P/E forward | 3.00 |
| Price/Sale | 311.04 |
| Beta | 1.13 |
| EPS | 3.00 |
| EPS United Kingdom (ID:3, base:630) | 3.00 |